Chapter One General Principles
Article 1
To further standardize the temporary suspension and exemption of information disclosure by Tonghua Golden Horse Pharmaceutical Group Co., Ltd. (hereinafter referred to as "the Company"), strengthen information disclosure supervision, and protect the legitimate rights and interests of investors, this system is formulated in accordance with the "Law of the People's Republic of China on Guarding State Secrets," "Securities Law of the People's Republic of China," "Administrative Measures for Information Disclosure of Listed Companies," "Regulations on Temporary Suspension and Exemption of Information Disclosure of Listed Companies," and other laws, regulations, normative documents, and the provisions of the "Articles of Association of Tonghua Golden Horse Pharmaceutical Group Co., Ltd." (hereinafter referred to as "the Articles of Association"), combined with the actual situation of the Company.
Article 2
The Company shall implement the temporary suspension and exemption of information disclosure in accordance with relevant laws and regulations and the business rules of the Shenzhen Stock Exchange (hereinafter referred to as "SZSE"). This system applies to such practices.
Article 3
The Company shall prudently assess the information that should be disclosed under relevant laws and regulations and SZSE business rules, and accept post-event supervision by the SZSE regarding matters of temporary suspension and exemption of information disclosure. The Company and other information disclosure obligors shall not abuse the temporary suspension or exemption of disclosure to evade disclosure obligations or mislead investors, nor engage in illegal activities such as insider trading or market manipulation.
Chapter Two Scope of Information for Temporary Suspension and Exemption
Article 4
If the Company and other information disclosure obligors have sufficient evidence proving that the information to be disclosed involves state secrets or other matters that may violate state confidentiality regulations and management requirements upon disclosure (hereinafter collectively referred to as "state secrets"), they shall be exempt from disclosure in accordance with relevant laws and regulations and this system. The Company and relevant information disclosure obligors shall comply with state confidentiality laws and fulfill confidentiality obligations, and shall not disclose state secrets through any form of information disclosure, investor interaction Q&A, press releases, interviews, etc., nor use the confidentiality of information as a pretext for business promotion. The Chairman of the Company and the Secretary of the Board shall enhance their legal awareness of guarding state secrets and ensure that disclosed information does not violate state confidentiality regulations.